IREN LTD (IREN) Fundamental Analysis & Valuation

NASDAQ:IREN • AU0000185993

Current stock price

39.32 USD
+2.26 (+6.1%)
At close:
38.19 USD
-1.13 (-2.87%)
Pre-Market:

This IREN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. IREN Profitability Analysis

1.1 Basic Checks

  • In the past year IREN was profitable.
  • IREN had a positive operating cash flow in the past year.
  • IREN had negative earnings in 4 of the past 5 years.
  • IREN had a positive operating cash flow in each of the past 5 years.
IREN Yearly Net Income VS EBIT VS OCF VS FCFIREN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

  • With an excellent Return On Assets value of 12.26%, IREN belongs to the best of the industry, outperforming 88.93% of the companies in the same industry.
  • IREN's Return On Equity of 18.19% is amongst the best of the industry. IREN outperforms 84.87% of its industry peers.
Industry RankSector Rank
ROA 12.26%
ROE 18.19%
ROIC N/A
ROA(3y)-17.1%
ROA(5y)-33.96%
ROE(3y)-18.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IREN Yearly ROA, ROE, ROICIREN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 50 -50 100

1.3 Margins

  • IREN has a better Profit Margin (76.17%) than 97.79% of its industry peers.
  • IREN's Operating Margin has improved in the last couple of years.
  • IREN has a Gross Margin of 49.79%. This is in the lower half of the industry: IREN underperforms 70.48% of its industry peers.
Industry RankSector Rank
OM N/A
PM (TTM) 76.17%
GM 49.79%
OM growth 3Y14.05%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IREN Yearly Profit, Operating, Gross MarginsIREN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. IREN Health Analysis

2.1 Basic Checks

  • IREN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for IREN has been increased compared to 1 year ago.
  • IREN has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for IREN is higher compared to a year ago.
IREN Yearly Shares OutstandingIREN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
IREN Yearly Total Debt VS Total AssetsIREN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 7.11 indicates that IREN is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of IREN (7.11) is better than 84.87% of its industry peers.
  • A Debt/Equity ratio of 0.34 indicates that IREN is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.34, IREN is not doing good in the industry: 60.52% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 7.11
ROIC/WACCN/A
WACC10.88%
IREN Yearly LT Debt VS Equity VS FCFIREN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 5.52 indicates that IREN has no problem at all paying its short term obligations.
  • The Current ratio of IREN (5.52) is better than 86.72% of its industry peers.
  • A Quick Ratio of 5.52 indicates that IREN has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 5.52, IREN belongs to the best of the industry, outperforming 86.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.52
Quick Ratio 5.52
IREN Yearly Current Assets VS Current LiabilitesIREN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. IREN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 618.29% over the past year.
  • The Revenue has grown by 163.17% in the past year. This is a very strong growth!
  • The Revenue has been growing by 196.84% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)618.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-263.04%
Revenue 1Y (TTM)163.17%
Revenue growth 3Y103.98%
Revenue growth 5Y196.84%
Sales Q2Q%62.75%

3.2 Future

  • IREN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.77% yearly.
  • IREN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 53.20% yearly.
EPS Next Y-93.62%
EPS Next 2Y-26.03%
EPS Next 3Y54.77%
EPS Next 5YN/A
Revenue Next Year99.55%
Revenue Next 2Y142.97%
Revenue Next 3Y106.53%
Revenue Next 5Y53.2%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
IREN Yearly Revenue VS EstimatesIREN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
IREN Yearly EPS VS EstimatesIREN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

2

4. IREN Valuation Analysis

4.1 Price/Earnings Ratio

  • IREN is valuated rather expensively with a Price/Earnings ratio of 23.13.
  • Compared to the rest of the industry, the Price/Earnings ratio of IREN indicates a somewhat cheap valuation: IREN is cheaper than 60.89% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.86. IREN is around the same levels.
  • IREN is valuated quite expensively with a Price/Forward Earnings ratio of 111.93.
  • IREN's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.39, IREN is valued quite expensively.
Industry RankSector Rank
PE 23.13
Fwd PE 111.93
IREN Price Earnings VS Forward Price EarningsIREN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IREN Per share dataIREN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as IREN's earnings are expected to grow with 54.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-26.03%
EPS Next 3Y54.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IREN Dividend Analysis

5.1 Amount

  • No dividends for IREN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IREN Fundamentals: All Metrics, Ratios and Statistics

IREN LTD

NASDAQ:IREN (4/10/2026, 8:00:02 PM)

Premarket: 38.19 -1.13 (-2.87%)

39.32

+2.26 (+6.1%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-05
Earnings (Next)05-12
Inst Owners40.97%
Inst Owner Change0.04%
Ins Owners2.96%
Ins Owner Change0%
Market Cap15.69B
Revenue(TTM)752.03M
Net Income(TTM)523.26M
Analysts80
Price Target74.38 (89.17%)
Short Float %13.35%
Short Ratio1.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)440.84%
Min EPS beat(2)319.92%
Max EPS beat(2)561.77%
EPS beat(4)3
Avg EPS beat(4)305.97%
Min EPS beat(4)-22.73%
Max EPS beat(4)561.77%
EPS beat(8)4
Avg EPS beat(8)-255.39%
EPS beat(12)6
Avg EPS beat(12)-201.02%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.04%
Min Revenue beat(2)-1.56%
Max Revenue beat(2)-0.52%
Revenue beat(4)1
Avg Revenue beat(4)-2.39%
Min Revenue beat(4)-8.9%
Max Revenue beat(4)1.42%
Revenue beat(8)3
Avg Revenue beat(8)-2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.49%
PT rev (3m)-5.39%
EPS NQ rev (1m)-12.89%
EPS NQ rev (3m)-172.61%
EPS NY rev (1m)-91.84%
EPS NY rev (3m)-95.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)-3.01%
Revenue NY rev (3m)-13.42%
Valuation
Industry RankSector Rank
PE 23.13
Fwd PE 111.93
P/S 22.84
P/FCF N/A
P/OCF 40.02
P/B 5.45
P/tB 5.45
EV/EBITDA N/A
EPS(TTM)1.7
EY4.32%
EPS(NY)0.35
Fwd EY0.89%
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)0.98
OCFY2.5%
SpS1.72
BVpS7.21
TBVpS7.21
PEG (NY)N/A
PEG (5Y)N/A
Graham Number16.61
Profitability
Industry RankSector Rank
ROA 12.26%
ROE 18.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 76.17%
GM 49.79%
FCFM N/A
ROA(3y)-17.1%
ROA(5y)-33.96%
ROE(3y)-18.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y14.05%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 108.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.52
Quick Ratio 5.52
Altman-Z 7.11
F-Score5
WACC10.88%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)114.65%
Cap/Sales(5y)115.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)618.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-263.04%
EPS Next Y-93.62%
EPS Next 2Y-26.03%
EPS Next 3Y54.77%
EPS Next 5YN/A
Revenue 1Y (TTM)163.17%
Revenue growth 3Y103.98%
Revenue growth 5Y196.84%
Sales Q2Q%62.75%
Revenue Next Year99.55%
Revenue Next 2Y142.97%
Revenue Next 3Y106.53%
Revenue Next 5Y53.2%
EBIT growth 1Y82.52%
EBIT growth 3Y132.63%
EBIT growth 5YN/A
EBIT Next Year614.47%
EBIT Next 3Y289.56%
EBIT Next 5Y122.45%
FCF growth 1Y-265.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y370.88%
OCF growth 3Y125.1%
OCF growth 5YN/A

IREN LTD / IREN Fundamental Analysis FAQ

What is the fundamental rating for IREN stock?

ChartMill assigns a fundamental rating of 5 / 10 to IREN.


What is the valuation status of IREN LTD (IREN) stock?

ChartMill assigns a valuation rating of 2 / 10 to IREN LTD (IREN). This can be considered as Overvalued.


Can you provide the profitability details for IREN LTD?

IREN LTD (IREN) has a profitability rating of 4 / 10.


What is the valuation of IREN LTD based on its PE and PB ratios?

The Price/Earnings (PE) ratio for IREN LTD (IREN) is 23.13 and the Price/Book (PB) ratio is 5.45.


What is the financial health of IREN LTD (IREN) stock?

The financial health rating of IREN LTD (IREN) is 5 / 10.